Company: FLDDW
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-026537
Chunk: 187

Company: Fold Holdings, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 187
---
 managing members of Investment Manager, in their capacity as managing members, may also be deemed to have investment discretion and voting power over the shares of Common Stock held by SPV. General Partner, Investment Manager, and the managing members each disclaim beneficial ownership of the shares held by SPV. The address of the principal business office of each of General Partner, Investment Manager, and SPV is 1 Pennsylvania Plaza, Suite 

# 4810, New York, New York 10119. |
| (4) | This number represents the number of shares of Common Stock beneficially                                                                     
 owned by this Selling Securityholder as of March 28, 2025 after giving effect to the Maximum Percentage (as defined below). Under the        
 terms of the SPV Initial Note and the SPV Warrants, a Selling Securityholder may not convert the SPV Notes or exercise the SPV Warrants      
 to the extent such Selling Securityholder or any of its affiliates would beneficially own a number of shares of our Common Stock which       
 would exceed 9.99% (the “Maximum Percentage”) of our outstanding shares. Applicable percentage ownership is based on 46,888,876              
 shares of Common Stock outstanding as of March 28, 2025. Without regard to the Maximum Percentage, as of March 28, 2025, this Selling        
 Securityholder would beneficially own an aggregate of 7,186,539 shares of our Common Stock, consisting of (1) 4,357,929 shares of Common     
 Stock underlying the SPV Initial Note, converted at an alternate exercise price of $6.24, none of which shares are being registered under    
 this prospectus, (2) 1,959,047 shares of Common Stock underlying the SPV Series A Warrants, exercisable at an exercise price of $12.50,      
 all of which shares are being registered under this prospectus, and (3) 869,565 shares of Common Stock underlying the SPV Series C Warrants, 
 exercisable at an exercise price of $11.50, all of which shares are being registered under this prospectus.                                  |

| (5) | For purposes of the calculations of Common Stock to be sold pursuant to this prospectus we are assuming                                       
 (a) the exercise of all of the SPV Series A Warrants and the SPV Series C Warrants and (b) that all of the additional notes issuable pursuant 
 to the SPV SPA have been issued as of